Video

Dr. Concepcion on Transition to Value-Based Model in Urology

Raoul Concepcion, MD, director of the Comprehensive Prostate Center, discusses the impending transition to a value-based model in urology.

Raoul Concepcion, MD, director of the Comprehensive Prostate Center, discusses the impending transition to a value-based model in urology.

The field is moving away from the traditional fee-for-service and many physicians have been hesitant to believe in the switch due to the high rate of tweaking and revising within the value-based system by the Centers for Medicare & Medicaid Services (CMS).

As per the CMS website, value-based programs are focused on paying providers based on the quality of care they give, not the quantity.

According to Concepcion, the way this transition plays out is vital to the future of way medicine is delivered.

Related Videos
Pooja Phull, MD
Jennifer Effie Amengual, MD
Michael R. Bishop, MD
Marwan G. Fakih, MD, discusses the FDA approval of sotorasib with panitumumab for the treatment of adult patients with KRAS G12C–mutated metastatic colorectal cancer.
C. Ola Landgren, MD, PhD
Aditya Bardia, MD, MPH, FASCO
FRCSI, FRCSEd, medical director, Thoracic Cancer Program, and associate executive director, AdventHealth Cancer Institute
Benjamin P. Levy, MD, clinical director, Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital; and associate professor, oncology, Johns Hopkins University School of Medicine
Russell Hales, MD, director, Thoracic Oncology Multidisciplinary Program, associate professor, clinical radiation oncology and molecular radiation sciences, and director, thoracic multidisciplinary clinic, John Hopkins University School of Medicine